Knoepfler is STAT’s Lab Dish columnist and a professor of cell biology and human anatomy at UC Davis School of Medicine. De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring ...

Dallas biotech startup Colossal just got a little more sci-fi. The company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its acquisition of Viagen, an ...

"This initiative will redefine conservation in the United States." ...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

In the bold and somewhat controversial field of de-extinction, Ben Lamm has become a prominent figure as the face of Colossal Biosciences. His mission? To bring back iconic species like the Woolly ...

The series will give viewers a behind-the-scenes look into the Dallas-based company's use of DNA and genetic engineering, as well as document the lives of extinct animals like woolly mammoths and ...

DALLAS--(BUSINESS WIRE)--The Colossal Foundation, the 501(c)(3) charitable organization of Colossal Biosciences, the de-extinction company, today announced the launch of its Species Reintroduction ...

Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. We know more about the vast expanses of our solar ...